Ireland is home to an unrivalled number of the world's leading life science and medical technology companies operating in areas such as Pharmaceuticals, Biotechnology, Medical Devices and Diagnostics across the R&D, production and distribution sectors. This includes ten of the top ten global pharmaceutical companies and thirteen of the top fifteen medical technology companies.
We have been at the centre of developments in this sector since the 1970s, with a team dedicated to the area. Our clients range from large and medium sized companies to emergent companies. We also regularly advise private equity and venture capital funds investing in the life sciences industry.
Our lawyers are widely recognised for providing innovative solutions, pioneering structures and having unparalleled market insight and relationships. These are the reasons why such a significant number of companies look to A&L Goodbody for the extensive range of specialist legal advice.
Our advice includes:
- Corporate and M&A - including joint ventures, private equity, restructuring and reorganisations
- Commercial contracts and agreements - including licensing, collaborative research and development, distribution agreements
- Patent litigation
- Pricing, refusal to supply, parallel trade, generic pricing, new pricing, and products going off patent
- Other specialists areas include EU, Competition & Procurement, Dispute Resolution, Tax, Employment and Commercial Property
on the proposed redomicile of its holding company from Austria to Ireland, by means of an exchange offer.
Sale of Creganna
to TE Connectivity for $895m.
on its €40m IPO and admission to the Official List of the Australian Securities Exchange.
on its IPO on the NASDAQ.
on the Irish defence of patent proceedings brought by Edwards Lifesciences PVT in the Commercial Court relating to the infringement of a patent concerning transcatheter heart valves.
in the defence of a Commercial Court patent infringement action taken by Fresenius Medical Care relating to a dialysis treatment product.